Traders Buy Large Volume of Call Options on Lifevantage (NASDAQ:LFVN)

Lifevantage Corporation (NASDAQ:LFVN) was the recipient of unusually large options trading on Wednesday. Investors bought 2,482 call options on the company. This represents an increase of approximately 747% compared to the average volume of 293 call options.

Insiders Place Their Bets

In related news, Director Judd Dayton acquired 18,097 shares of the stock in a transaction on Friday, February 27th. The shares were bought at an average price of $4.63 per share, with a total value of $83,789.11. Following the completion of the purchase, the director owned 69,859 shares of the company’s stock, valued at approximately $323,447.17. This represents a 34.96% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders acquired a total of 34,252 shares of company stock worth $157,940 over the last quarter. Insiders own 21.95% of the company’s stock.

Institutional Investors Weigh In On Lifevantage

A number of institutional investors have recently made changes to their positions in the stock. Capital Management Corp VA lifted its holdings in shares of Lifevantage by 63.0% in the 3rd quarter. Capital Management Corp VA now owns 2,064,176 shares of the company’s stock worth $20,084,000 after acquiring an additional 798,066 shares during the last quarter. Franklin Resources Inc. purchased a new position in shares of Lifevantage during the 4th quarter worth approximately $74,000. JPMorgan Chase & Co. increased its holdings in Lifevantage by 870.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock valued at $66,000 after purchasing an additional 4,499 shares during the last quarter. Bank of America Corp DE increased its holdings in Lifevantage by 24.3% in the 1st quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock valued at $101,000 after purchasing an additional 4,586 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in Lifevantage by 11.9% in the first quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after purchasing an additional 3,571 shares during the period. 35.32% of the stock is currently owned by institutional investors and hedge funds.

Lifevantage Trading Up 9.1%

Lifevantage stock traded up $0.63 during mid-day trading on Wednesday, hitting $7.56. The company’s stock had a trading volume of 401,071 shares, compared to its average volume of 196,553. The stock’s fifty day moving average is $4.85 and its two-hundred day moving average is $5.53. The firm has a market capitalization of $95.46 million, a PE ratio of 16.57 and a beta of 0.52. Lifevantage has a 1 year low of $3.90 and a 1 year high of $15.00.

Lifevantage (NASDAQ:LFVN) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). The business had revenue of $43.72 million during the quarter, compared to analyst estimates of $47.77 million. Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. On average, equities analysts expect that Lifevantage will post 0.6 EPS for the current fiscal year.

Lifevantage Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.05 dividend. The ex-dividend date of this dividend is Monday, June 1st. This is an increase from Lifevantage’s previous quarterly dividend of $0.05. This represents a $0.20 dividend on an annualized basis and a yield of 2.6%. Lifevantage’s dividend payout ratio is currently 40.00%.

Analyst Ratings Changes

Several brokerages have recently weighed in on LFVN. Lake Street Capital cut shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target on the stock. in a research report on Thursday, May 7th. Loop Capital set a $5.00 price objective on shares of Lifevantage in a research report on Thursday, February 5th. Finally, Weiss Ratings downgraded shares of Lifevantage from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 4th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $5.00.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.